RiKarbon, Inc. was recognized for its work in environmentally acceptable lubricants as a TechConnect Innovation awardee at the TechConnect World Innovation Conference this month in Boston, MA. RiKarbon placed in the top 15% of submitted technologies as ranked by the TechConnect Corporate and Investment Partner Committee. Innovation rankings are based on the potential positive impact the technology will have on a specific industry.
Archives for July 2019
DRIVEN Partnership Program
UD medical inventors and entrepreneurs invited to apply through July 23
The DRIVEN Accelerator Hub, of which the University of Delaware is a collaborator, has announced a pilot program that will provide opportunities for medical start-ups and inventors to pitch their ideas to potential investors and business development leaders.
Driving Clean Energy Forward
The electric grid that keeps our home lights burning and our city streets from being in the shadows is about to have a new resource at its disposal — the vehicle parked in your driveway.
Prelude Therapeutics Secures $60 Million and Expands Management Team to Develop Drugs Targeting Novel Molecular Mechanisms in Cancer
Prelude Therapeutics, a privately held, clinical-stage biopharmaceutical company focused on the discovery and development of small molecule drugs that target key drivers of cancer cell growth, survival and resistance, secured $60 million in Series B financing; taking its total investments to date to $95 million. The financing was co-led by Prelude’s two existing institutional investors, including OrbiMed Advisors LLC.